glp-1 drugs and alzheimer's Can Weight Loss Treat Alzheimer’s? CKD Dementia Risk Reduced with

Numerous studies have investigated the expression patterns of endogenous GLP-1 and GLP-1R in the central nervous system (CNS) and the peripheral nervous system, with a consensus that these are expressed on neurons and found in most areas of the brain and gutbrain axis 2

W.LeiT.LiuW.et al (2024)

Lilly CEO David Ricks framed the approval in terms of access: " Today, fewer than 1 in 10 people who could benefit from a GLP-1 are taking one, held back by access, stigma, perceived complexity or the belief that their condition isn't serious enough for treatment, " Ricks said in the company's April 1 press release

His employer, the Department of Veterans Affairs, had no interest in commercializing the discovery